Type I BMP receptor inhibitor (Ki values are <1, 5.4 and 43 nM for ALK6, ALK3 and ALK2, respectively). Exhibits >30-fold selectivity over ALK4, ALK5, BMPR2, AMPK and VEGFR2. Also binds to TGFBR2 (Ki = 85 nM). Decreases growth and induces cell death of H1299 non-small cell lung carcinoma cells in vitro. Enhances liver regeneration in vivo.
|Storage||Store at +4°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
|DMSO||9.03||20mM with gentle warming|
Preparing Stock Solutions
The following data is based on the product molecular weight 451.52. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.21 mL||11.07 mL||22.15 mL|
|5 mM||0.44 mL||2.21 mL||4.43 mL|
|10 mM||0.22 mL||1.11 mL||2.21 mL|
|50 mM||0.04 mL||0.22 mL||0.44 mL|
References are publications that support the products' biological activity.
Tsugawa et al (2014) Specific activin receptor-like kinase 3 inhibitors enhance liver regeneration. J.Pharmacol.Exp.Ther. 351 549 PMID: 25271257
If you know of a relevant reference for DMH2, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: DMH2, supplier, Type-1, BMP, bone, morphogenetic, protein, receptors, inhibitors, inhibits, ALK6, ALK2, ALK3, BMP, and, Other, Activin, Receptors, BMP, and, Other, Activin, Receptors, Tocris Bioscience
Citations for DMH2
Citations are publications that use Tocris products.
Currently there are no citations for DMH2. Do you know of a great paper that uses DMH2 from Tocris? If so please let us know.
Average Rating:(Based on 0 Reviews)